Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 50

Results For "MD"

2310 News Found

Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact
Hospitals | April 09, 2026

Metropolis’ ARSH initiative touches 3.25 Lakh adolescents, deepening grassroots health impact

CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change


Kokilaben hospital performs first remote robotic kidney surgery
Hospitals | April 09, 2026

Kokilaben hospital performs first remote robotic kidney surgery

Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat


OPPI and NIPER Raebareli partner to boost pharma research and talent
News | April 09, 2026

OPPI and NIPER Raebareli partner to boost pharma research and talent

Scholarships, research grants and industry mentorship framework aim to strengthen India’s pharma R&D ecosystem


BOTOX Cosmetic launches programme to empower 250 women entrepreneurs
News | April 09, 2026

BOTOX Cosmetic launches programme to empower 250 women entrepreneurs

20 among them to receive $20,000 grants


University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders
Hospitals | April 09, 2026

University of Leeds launches landmark HALO study on lifelong impact of childhood blood disorders

Backed by a £680,000 grant from Leeds Hospitals Charity, the study is jointly led by academics and clinicians from the University of Leeds and Leeds Teaching Hospitals NHS Trust


HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care
Hospitals | April 09, 2026

HCG Bengaluru pushes distress screening as ‘6th vital sign’ in cancer care

The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment


Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio
Biotech | April 09, 2026

Gilead to acquire Tubulis for up to $5 billion to strengthen its oncology portfolio

The acquisition complements Gilead’s existing oncology expertise and development infrastructure


Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study
News | April 09, 2026

Insmed’s Brensocatib fails to hit endpoints in hidradenitis suppurativa study

The results were consistent across both the 10 mg and 40 mg treatment arms


IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals
Digitisation | April 08, 2026

IndiaAI, CDSCO launch hackathon to accelerate health innovation approvals

AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17